We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. The Administrator of personal data is STOCKTRADEIQ sp. z o.o., with its registered office in Poznan (61-625), at the following address: Czarna Rola 30 Street. Cookies policy here. By clicking "Accept All", you consent to our use of cookies.

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

  • Cookie
    cookieyes-consent
  • Duration
    1 year
  • Description
    CookieYes sets this cookie to remember users' consent preferences so that their preferences are respected on their subsequent visits to this site. It does not collect or store any personal information of the site visitors.
  • Cookie
    x-ms-cpim-csrf
  • Duration
    session
  • Description

    Inter-site request forgery token used to protect crSF. For more information, read the section Token falsification of requests between sites.

  • Cookie
    x-ms-cpim-sso:stocktradeiqauth.onmicrosoft.com_0
  • Duration
    session
  • Description

    Used to support single sign-on sessions. This cookie is set as persistent when the Keep me logged in option is enabled.

  • Cookie
    server-telemetry-{id}
  • Duration
    persistent
  • Description

    A value used by Microsoft for authorisation and authentication.

  • Cookie
    google_auto_fc_cmp_setting
  • Duration
    persistent
  • Description


    Stores the state of the User cookie for the current domain.

     

  • Cookie
    {id}-https://stocktradeiqauth.onmicrosoft.com/{id}
  • Duration
    persistent
  • Description

    Stores information about the logged-in user's session.

  • Cookie
    msal{id}.active-account
  • Duration
    persistent
  • Description

    Stores information about the logged-in user's session.

  • Cookie
    {id}signinup{id}stocktradeiqauth.b2clogin.com-refreshtoken
  • Duration
    persistent
  • Description

    Stores information about the logged-in user's session.

  • Cookie
    {id}signinup{id}stocktradeiqauth.b2clogin.com-idtoken
  • Duration
    persistent
  • Description

    Stores information about the logged-in user's session.

  • Cookie
    {id}signinup{id}stocktradeiqauth.b2clogin.com
  • Duration
    persistent
  • Description

    Stores information about the logged-in user's session.

  • Cookie
    Microsoft Clarity
  • Duration
    1 year
  • Description

    Microsoft Clarity

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

  • Cookie
    isLightMode
  • Duration
    1 year
  • Description

    Defines the UI theme

  • Cookie
    userCultureData
  • Duration
    persistent
  • Description

     Stores information about the user's machine culture.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

  • Cookie
    _ga
  • Duration
    1 year 1 month 4 days
  • Description
    The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
  • Cookie
    _ga_*
  • Duration
    1 year 1 month 4 days
  • Description
    Google Analytics sets this cookie to store and count page views.
  • Cookie
    hotjar
  • Duration
    1 year 1 month 4 days
  • Description

    Analyzing users' behaviour in the website

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

  • Cookie
    __gpi
  • Duration
    1 year 24 days
  • Description
    Google Ads Service uses this cookie to collect information about from multiple websites for retargeting ads.
  • Cookie
    __gads
  • Duration
    1 year 24 days
  • Description

    The file, set by Google, is stored in the DoubleClick domain and tracks the number of times users view an ad, measures the success of the campaign and calculates its revenue. This cookie can only be read from the domain where it is set and does not track any data when browsing other sites.

  • Cookie
    goog:cached:topics
  • Duration
    persistent
  • Description

    It is used to record which adverts have been displayed to the User.

  • Cookie
    IDE
  • Duration
    year
  • Description

    Used by Google DoubleClick to record and report on the Website User's actions after viewing or clicking on an advertiser's ads in order to measure the effectiveness of the ad and present the User with targeted advertising.

  • Cookie
    google_experiment_mod44
  • Duration
    persistent
  • Description

    Used by Google Ad to experiment with the effectiveness of ads on websites using their services.

Powered by Cookieyes logo

    Get Diamond plan for FREE

    logo

    Nocturne Acquisition Corporation (MBTC)

    Price:

    11.66 USD

    ( + 0.46 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    MBTC
    Name
    Nocturne Acquisition Corporation
    Industry
    Shell Companies
    Sector
    Financial Services
    Price
    11.660
    Market Cap
    60.532M
    Enterprise value
    97.331M
    Currency
    USD
    Ceo
    Henry Monzon
    Full Time Employees
    2
    Website
    nocturnecorp.com
    Ipo Date
    2021-05-05
    City
    Wilmington
    Address
    3 Germay Drive

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Centurion Acquisition Corp.

    VALUE SCORE:

    5

    Symbol
    ALFUW
    Market Cap
    377.703M
    Industry
    Shell Companies
    Sector
    Financial Services

    2nd position

    Melar Acquisition Corp. I

    VALUE SCORE:

    11

    Symbol
    MACI
    Market Cap
    227.027M
    Industry
    Shell Companies
    Sector
    Financial Services

    The best

    M3-Brigade Acquisition V Corp. Units

    VALUE SCORE:

    11

    Symbol
    MBAVU
    Market Cap
    280.000M
    Industry
    Shell Companies
    Sector
    Financial Services
    FUNDAMENTALS
    P/E
    -281.247
    P/S
    0
    P/B
    8.265
    Debt/Equity
    0.205
    EV/FCF
    -50.164
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    0
    Earnings yield
    -0.004
    Debt/assets
    0.122
    FUNDAMENTALS
    Net debt/ebidta
    -1.237
    Interest coverage
    0
    Research And Developement To Revenue
    0
    Intangile to total assets
    0
    Capex to operating cash flow
    0
    Capex to revenue
    0
    Capex to depreciation
    0
    Return on tangible assets
    -0.017
    Debt to market cap
    0.043
    Piotroski Score
    1.000
    FUNDAMENTALS
    PEG
    -2.812
    P/CF
    -82.557
    P/FCF
    -48.150
    RoA %
    -1.739
    RoIC %
    -3.263
    Gross Profit Margin %
    0
    Quick Ratio
    0.026
    Current Ratio
    0.026
    Net Profit Margin %
    0
    Net-Net
    -0.968
    FUNDAMENTALS PER SHARE
    FCF per share
    -0.141
    Revenue per share
    0
    Net income per share
    -0.041
    Operating cash flow per share
    -0.141
    Free cash flow per share
    -0.141
    Cash per share
    0.005
    Book value per share
    1.411
    Tangible book value per share
    1.411
    Shareholders equity per share
    1.411
    Interest debt per share
    0.290
    TECHNICAL
    52 weeks high
    13.980
    52 weeks low
    9.450
    Current trading session High
    11.730
    Current trading session Low
    11.440
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo
    Country
    Sector
    Financial Services
    Industry
    Shell Companies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.000

    No data to display

    logo
    Country
    BM
    Sector
    Financial Services
    Industry
    Shell Companies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.000

    No data to display

    logo
    Country
    US
    Sector
    Financial Services
    Industry
    Shell Companies
    Dividend yield
    0%
    Payout Ratio
    293.7833%
    P/E
    256.490

    No data to display

    logo
    Country
    US
    Sector
    Financial Services
    Industry
    Shell Companies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -36.054

    No data to display

    logo
    Country
    US
    Sector
    Financial Services
    Industry
    Shell Companies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    60.934
    DESCRIPTION

    Nocturne Acquisition Corporation does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the disruptive technology market. The company was incorporated in 2020 and is based in Wilmington, Delaware.

    NEWS
    https://images.financialmodelingprep.com/news/chardan-engaged-to-facilitate-nocturne-acquisition-corporations-business-combination-20230920.jpg
    Chardan Engaged to Facilitate Nocturne Acquisition Corporation's Business Combination with Cognos Therapeutics, Inc., Paving the Way for NASDAQ Listing

    globenewswire.com

    2023-09-20 18:35:00

    WILMINGTON, Del. and INGLEWOOD, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Nocturne Acquisition Corporation (NASDAQ:MBTC, MBTCU, MBTCR) ("Nocturne") and Cognos Therapeutics, Inc. (“Cognos”) today announced the engagement of Chardan, a leading global investment bank, in the role of capital markets advisor to Nocturne in the highly anticipated business combination transaction (the “Business Combination”) with Cognos. This strategic move marks Cognos's journey towards becoming a publicly traded company on the NASDAQ Stock Exchange.

    https://images.financialmodelingprep.com/news/nocturne-acquisition-corporation-announces-filing-of-a-registration-statement-20230816.jpg
    Nocturne Acquisition Corporation Announces Filing of a Registration Statement on Form S-4 in Connection with its Proposed Business Combination with Cognos

    accesswire.com

    2023-08-16 08:05:00

    Transaction Expected to Accelerate the Research and Advancement of Cognos' Proprietary and Innovative Implantable Drug Delivery Pump to Improve Outcomes for Treatment of Brain Cancers and Other Neurological Diseases WILMINGTON, DE / ACCESSWIRE / August 16, 2023 / Nocturne Acquisition Corporation (NASDAQ:MBTC)(NASDAQ:MBTCU)(NASDAQ:MBTCR) (the "Company", "MBTC" or "Nocturne"), today announced the submission via Edgar, the U.S. Securities and Exchange Commission's ("SEC") online portal, for filing of a registration statement on Form S-4 (the "Registration Statement") with the SEC, which includes a preliminary proxy statement/prospectus in connection with the proposed business combination (the "Business Combination") with Cognos Therapeutics, Inc. ("Cognos"), a medical technology company focused on developing unique, radically advanced devices for the treatment of neurological diseases including brain and spinal cancers, and degenerative neurological conditions (such as Alzheimer's and Parkinson's disease), epilepsy, and stroke. The Registration Statement contains a preliminary proxy statement/prospectus in connection with the previously announced Business Combination between Nocturne and Cognos.